Financials data is unavailable for this security.
View more
Year on year Alliance Pharma PLC had net income fall 56.24% from a loss of 21.21m to a larger loss of 33.14m despite a 7.92% increase in revenues from 167.42m to 180.68m. An increase in the cost of goods sold as a percentage of sales from 39.26% to 41.88% was a component in the falling net income despite rising revenues.
| Gross margin | 58.12% |
|---|---|
| Net profit margin | -18.34% |
| Operating margin | -21.28% |
| Return on assets | -7.17% |
|---|---|
| Return on equity | -13.71% |
| Return on investment | -7.92% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Alliance Pharma PLC fell by 9.28m. However, the company earned 31.41m from its operations for a Cash Flow Margin of 17.38%. In addition the company used 918.00k on investing activities and also paid 39.19m in financing cash flows.
| Cash flow per share | -0.0422 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.4032 |
|---|---|
| Tangible book value per share | -0.1519 |
More ▼
Balance sheet in GBPView more
| Current ratio | 2.57 |
|---|---|
| Quick ratio | 1.93 |
| Total debt/total equity | 0.5389 |
|---|---|
| Total debt/total capital | 0.3502 |
More ▼
Growth rates in GBP
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -100.00% and -56.07%, respectively.
| Div yield(5 year avg) | 1.48% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -55.03 |
More ▼
